The global ophthalmic drugs market is projected to grow at a significant CAGR of around 5% during the forecast period. the market growth is attributed to the increasing prevalence of various eye disorders that increase the demand for efficient treatment and hence drives the growth of the global ophthalmic drugs market.
Browse the full report description Global Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, and Others), By Drug Class (Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-infective Drugs, Dry Eye Drugs, Retinal Drugs, Other Drugs), Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/ophthalmic-drugs-market
Geographically, the global ophthalmic drugs industry is segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America is expected to hold a significant share in the global market during the forecast period. This is attributed to the presence of well-established healthcare infrastructure in the region. In addition, the increased prevalence of ophthalmic disorders, rising prevalence of chronic diseases. The leading causes of blindness in the region include cataract, diabetic retinopathy (DRP), damaged cornea, macular degeneration, glaucoma, refractive errors, and others.
Besides, the geriatric population plays a vital role in expanding the market size as this population pool is at increased risk of acquiring eye disorder. According to the Statistics Times, the population of North America as of 2017 was 582.4 million. Half the population of North America is over 40 years of age due to an increase in the average life expectancy of people. As the elder people are more susceptible to cataracts and other eye-related problems and creates scope for the market growth.
Whereas, the market in Asia-Pacific is driven by numerous factors including increasing government initiatives such as the National Programme for Control of Blindness. As per the estimation of the International Diabetes Federation (IDF) in 2018, 382 million people had diabetes globally, and by 2035, this number was predicted to rise to 592 million. 80% of this population lives in under-developed and developing countries, and of the total, more than 60% live in Asia, with almost one-third in China.
Major increases in the prevalence of diabetes have occurred in developing countries including India and China due to rapid and ongoing socio-economic transition and will likely lead to further rise. According to the International Diabetes Federation, in 2018, 79% of adults with diabetes were living in developing and under-developed countries some of which leads to diabetic retinopathy. Also, the World Health Organization states that China had the largest number with 8 million blind and 75 million visually impaired individuals. Thus, these factors altogether create opportunities for market growth.
Current Market Trends Covered in the Global Ophthalmic Drugs Market Report:
Global Ophthalmic Drugs Market – Segmentation
By Indication
By Drug Class
Global Ophthalmic Drugs Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To
learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/ophthalmic-drugs-market